Contact Us
Blog
Subscribe to this list via RSS Blog posts tagged in Stryker hip implant

OtisMed recall, knee replacement liability, Chicago injury attorneyThe OtisKnee device, made by OtisMed Corporation, was not approved by the Food and Drug Administration (FDA) to be used in knee replacement surgeries. The OtisKnee devices were not proven to be safe or effective. OtisMed Corporation distributed and marketed the OtisKnee and is responsible for product liability and the injuries patients have been caused due to the defective product.

“The OtisKnee device was used by surgeons performing total knee arthroplasty, known as knee replacement surgery. OtisMed advertised the cutting guide as a tool to assist surgeons in making accurate bone cuts specific to individual patients’ anatomy based on magnetic resonance imaging (MRI) performed prior to surgery,” according to the FDA’s statement about the OtisKnee, following a lengthy investigation.

The OtisKnee device was marketed to surgeons as a means to match the size and placement of the implant to an individual’s normal knee alignment. It was supposed to allow surgeons to be able to keep more of the patient’s bone and ligaments, which meant a quicker recovery and greater range of motion. Patients claimed their recovery was longer and many have had to undergo a second knee replacement surgery to remove the defective product, more bone, and have a new implant placed in their knee, costing them more recovery time and more medical expenses.

...

Stryker hip implant settlement, Chicago product liability attorneyA settlement involving a minimum award of $1.43 billion has been reached in ongoing product liability litigation against Stryker Orthopedics. The 3,000-plus clients represented in the Stryker hip implant lawsuit will each receive a base amount of $300,000 with additional compensation for those who suffered revision surgery complications to remove the defective hip implant.

Stryker manufactured and promoted its Rejuvenate and ABG II Modular-Neck Hips implants as having the capability of providing longer life and greater range of motion for patients. The FDA approved Stryker’s Rejuvenate Modular hip system in 2008 as part of a 510(k) premarket application, which determined the hip implant was “substantially equivalent” to pre-approved, legally marketed medical devices.

The Centers for Disease Control and Prevention reported 332,000 hip replacements in 2010. Two years later, Stryker issued a recall of its Rejuvenate and ABG II Modular-Neck Hips implants due to dangers resulting from the poor design and improper testing of the device. Studies showed that patients faced health risks including:

...
To Top